Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 222

The DOI matches its Crossref record.

Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease

Open access
Kluijtmans, Leo A. J., Kastelein, John J. P., Lindemans, Jan, Boers, Godfried H. J., Heil, Sandra G., Bruschke, Albert V. G., Jukema, J. Wouter, van den Heuvel, Lambert P. W. J., Trijbels, Frans J. M., Boerma, Geert J. M., Verheugt, Freek W. A., Willems, Frank, Blom, Henk J. · 1997 · Circulation

Abstract

Background Hyperhomocysteinemia, an independent and graded risk factor for coronary artery disease (CAD), may result from both environmental and hereditary factors. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of methylenetetrahydrofolate to methyltetrahydrofolate, the methyl donor in the remethylation of homocysteine to methionine. A 677C→T mutation in the MTHFR gene has been associated with elevated homocysteine concentrations in homozygous (+/+) individuals. Methods and Results We assessed the frequency of this common mutation in 735 CAD patients from the Regression Growth Evaluation Statin Study (REGRESS), a lipid-lowering coronary-regression trial, and in 1250 population-based control subjects. Furthermore, the association between the mutation and serum homocysteine concentrations was studied. The frequency of the homozygous (+/+) mutation was 9.5% among patients versus 8.5% among control subjects, resulting in an odds ratio of 1.21 (95% confidence interval [CI], 0.87 to 1.68), relative to the (−/−) genotype. Homocysteine concentrations were significantly elevated in both (+/+) and (+/−) individuals compared with (−/−) individuals (median homocysteine levels, 15.4, 13.4, and 12.6 μmol/L, for (+/+), (+/−), and (−/−) individuals, respectively). For a summary estimation of the risk of the (+/+) genotype for CAD, we performed a meta-analysis on 8 different case-control studies on thermolabile MTHFR in CAD. In the meta-analysis, the homozygous (+/+) genotype was present in 299 of 2476 patients (12.1%) and in 257 (10.4%) of 2481 control subjects, resulting in a significant odds ratio of 1.22 (95% CI, 1.01 to 1.47) relative to the (−/−) genotype. Conclusions Both the homozygous (+/+) and heterozygous (+/−) genotype result in elevated homocysteine concentrations. From our meta-analysis, we conclude that the homozygous (+/+) genotype is a modest but significant risk factor for CAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.96.8.2573

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 222

Metadata

Authors
Kluijtmans, L. A. J., Kastelein, J. J. P., Lindemans, J., Boers, G. H. J., Heil, S. G., Bruschke, A. V. G., Jukema, J. W., van den Heuvel, L. P. W. J., Trijbels, F. J. M., Boerma, G. J. M., Verheugt, F. W. A., Willems, F., & Blom, H. J.
Venue
Circulation
Published
1997-10-21
Volume
96
Issue
8
Pages
2573-2577
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2056767200
Cited by
222
References
0
FWCI
13.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease. https://app.cochat.ai/papers/10.1161/01.cir.96.8.2573
The paper
Kluijtmans, L. A. J., Kastelein, J. J. P., Lindemans, J., Boers, G. H. J., Heil, S. G., Bruschke, A. V. G., Jukema, J. W., van den Heuvel, L. P. W. J., Trijbels, F. J. M., Boerma, G. J. M., Verheugt, F. W. A., Willems, F., & Blom, H. J. (1997). Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease. Circulation. https://doi.org/10.1161/01.cir.96.8.2573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.